Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice
Open accessThe DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Abstract
Although elevated activity of the tryptophan-degrading enzyme indoleamine 2,3-dioxygenase (IDO) has been proposed to mediate comorbid depression in inflammatory disorders, its causative role has never been tested. We report that peripheral administration of lipopolysaccharide (LPS) activates IDO and culminates in a distinct depressive-like behavioral syndrome, measured by increased duration of immobility in both the forced-swim and tail suspension tests. Blockade of IDO activation either indirectly with the anti-inflammatory tetracycline derivative minocycline, that attenuates LPS-induced expression of proinflammatory cytokines, or directly with the IDO antagonist 1-methyltryptophan (1-MT), prevents development of depressive-like behavior. Both minocycline and 1-MT normalize the kynurenine/tryptophan ratio in the plasma and brain of LPS-treated mice without changing the LPS-induced increase in turnover of brain serotonin. Administration of L-kynurenine, a metabolite of tryptophan that is generated by IDO, to naive mice dose dependently induces depressive-like behavior. These results implicate IDO as a critical molecular mediator of inflammation-induced depressive-like behavior, probably through the catabolism of tryptophan along the kynurenine pathway.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“depressive-like behaviors in rodents are mediated by an enzyme that degrades tryptophan, called indoleamine 2,3dioxygenase (IDO; O'Connor et al., 2009; see also Maes et al., 2011)”
From From stress to inflammation and major depressive disorder: A social signal transduction theory of depression. (2014) · cites this paper as O'Connor et al., 2009
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Animal studies have shown that inflammation promotes a pattern of behavior known as sickness behavior that includes symptoms of depression, such as fatigue, anhedonia, and social withdrawal.[10,11]”
From SUICIDAL IDEATION IS ASSOCIATED WITH ELEVATED INFLAMMATION IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER: Research Article: Suicidal Ideation and Inflammation (2013) · cites this paper as [10]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Interestingly, blocking glutamate receptors with ketamine or inhibiting IDO activity protects mice from LPS- or stress-induced depressive-like behaviour but leaves the inflammatory response intact85,86.”
From The role of inflammation in depression: from evolutionary imperative to modern treatment target (2016) · cites this paper as [86]
Experimental — accuracy not yet measuredIn the citing paper
“In preclinical models, LPS-induced depressive behavior is mediated by IDO activation (O’Connor et al., 2009).”
From The role of inflammation in core features of depression: Insights from paradigms using exogenously-induced inflammation. (2018) · cites this paper as O’Connor et al., 2009
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
Lang, U. E., & Borgwardt, S. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350094 · Cited by 8,475
From inflammation to sickness and depression: when the immune system subjugates the brain
Dantzer, R., O'Connor, J. C., Freund, G. G., Johnson, R. W., & Kelley, K. W. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2297 · Cited by 7,395
Self-citationPrevention of Allogeneic Fetal Rejection by Tryptophan Catabolism
Munn, D. H., Zhou, M., Attwood, J. T., Bondarev, I., Conway, S. J., Marshall, B., Brown, C., & Mellor, A. L. (1998) · Science · doi:10.1126/science.281.5380.1191 · Cited by 2,585
Ido expression by dendritic cells: tolerance and tryptophan catabolism
Mellor, A. L., & Munn, D. H. (2004) · Nature Reviews Immunology · doi:10.1038/nri1457 · Cited by 2,341
Uyttenhove, C., Pilotte, L., Théate, I., Stroobant, V., Colau, D., Parmentier, N., Boon, T., & Van den Eynde, B. J. (2003) · Nature Medicine · doi:10.1038/nm934 · Cited by 2,305
Mood disorders in the medically ill: scientific review and recommendations
Evans, D. L., Charney, D. S., Lewis, L., Golden, R. N., Gorman, J. M., Krishnan, K. R. R., Nemeroff, C. B., Bremner, J. D., Carney, R. M., Coyne, J. C., et al. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.05.001 · Cited by 1,071
Zhu, S., Stavrovskaya, I. G., Drozda, M., Kim, B. Y. S., Ona, V., Li, M., Sarang, S., Liu, A. S., Hartley, D. M., Wu, D. C., et al. (2002) · Nature · doi:10.1038/417074a · Cited by 1,067
Potential Regulatory Function of Human Dendritic Cells Expressing Indoleamine 2,3-Dioxygenase
Munn, D. H., Sharma, M. D., Lee, J. R., Jhaver, K. G., Johnson, T. S., Keskin, D. B., Marshall, B., Chandler, P., Antonia, S. J., Burgess, R., et al. (2002) · Science · doi:10.1126/science.1073514 · Cited by 1,028
Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia
Yrjänheikki, J., Keinänen, R., Pellikka, M., Hökfelt, T., & Koistinaho, J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15769 · Cited by 1,006
Cytokine-induced sickness behaviour: mechanisms and implications
Konsman, J. P., Parnet, P., & Dantzer, R. (2002) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)02088-9 · Cited by 999
Self-citation
Cited by
Items 301–400 of 1,001
Role of Inflammation in Depression: Implications for Phenomenology, Pathophysiology and Treatment
Raison, C. L., & Miller, A. H. (2013) · Modern Trends in Psychiatry · doi:10.1159/000343966 · Cited by 88
Tang, M., Liu, T., Jiang, P., & Dang, R. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105586 · Cited by 88
Laumet, G., Zhou, W., Dantzer, R., Edralin, J. D., Huo, X., Budac, D. P., O'Connor, J. C., Lee, A. W., Heijnen, C. J., & Kavelaars, A. (2017) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2017.07.008 · Cited by 82
Self-citationCognitive and Behavioral Consequences of Impaired Immunoregulation in Aging
Corona, A. W., Fenn, A. M., & Godbout, J. P. (2011) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-011-9313-4 · Cited by 94
“associated with LPS injection in adult mice (O’Connor et al. 2009).”
BackgroundInfluentialThe saturated fatty acid, palmitic acid, induces anxiety-like behavior in mice
Moon, M. L., Joesting, J. J., Lawson, M. A., Chiu, G. S., Blevins, N. A., Kwakwa, K. A., & Freund, G. G. (2014) · Metabolism · doi:10.1016/j.metabol.2014.06.002 · Cited by 94
“Mouse brain regions were solubilized as previously described [36] in 0.”
MethodSelf-citationNumakawa, T., Richards, M., Nakajima, S., Adachi, N., Furuta, M., Odaka, H., & Kunugi, H. (2014) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2014.00136 · Cited by 86
Jovanović, F., Candido, K. D., & Knežević, N. N. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21176045 · Cited by 88
“Pretreatment with minocycline or 1-d-MT in mice with systemic, LPS-induced inflammation reflected significant changes with respect to KYN concentrations [60].”
BackgroundThe Evidence for a Causal Link Between Disease and Damaging Behavior in Pigs
Boyle, L. A., Edwards, S. A., Bolhuis, J. E., Pol, F., Šemrov, M. Z., Schütze, S., Nordgreen, J., Bozakova, N., Sossidou, E. Ν., & Valros, A. (2022) · Frontiers in Veterinary Science · doi:10.3389/fvets.2021.771682 · Cited by 95
Tang, M., Lin, W., Pan, Y., Guan, X., & Li, Y. (2016) · Physiology & Behavior · doi:10.1016/j.physbeh.2016.04.034 · Cited by 92
“behavioral effects (24-28 h) following LPS injection [7, 30].”
Implications of Systemic Inflammation and Periodontitis for Major Depression
Hashioka, S., Inoue, K., Hayashida, M., Wake, R., Oh‐Nishi, A., & Miyaoka, T. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00483 · Cited by 97
“They have established a murine model of inflammation-induced depression using systemic administration of LPS and claim that the LPS-induced depressive-like behavior can be distinguished from sickness behavior in the animal model (Dantzer et al., 2008; O’Connor et al., 2009).”
BackgroundVieira, G., Cavalli, J., Gonçalves, E. C. D., Braga, S. F. P., Ferreira, R. S., Santos, A. R. S., Cola, M., Raposo, N. R. B., Capasso, R., & Dutra, R. C. (2020) · Biomolecules · doi:10.3390/biom10050792 · Cited by 85
Smith, A. K., Simon, J. S., Gustafson, E. L., Noviello, S., Cubells, J. F., Epstein, M. P., Devlin, D. J., Qiu, P., Albrecht, J. K., Brass, C. A., et al. (2012) · Molecular Psychiatry · doi:10.1038/mp.2011.67 · Cited by 84
Visceral Inflammation and Immune Activation Stress the Brain
Holzer, P., Farzi, A., Hassan, A. M., Zenz, G., Jačan, A., & Reichmann, F. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01613 · Cited by 84
“Importantly, the IDO antagonist 1-methyl-d,l-tryptophan is able to block LPS-induced depression-like behavior, while the levels of proinflammatory cytokines and sickness behavior remain unchanged (191).”
BackgroundNordgreen, J., Munsterhjelm, C., Aae, F., Popova, A., Boysen, P., Ranheim, B., Heinonen, M., Raszplewicz, J., Piepponen, P. T., Lervik, A., et al. (2018) · Physiology & Behavior · doi:10.1016/j.physbeh.2018.07.013 · Cited by 93
Ali, T., Hao, Q., Ullah, N., Rahman, S. U., Shah, F. A., He, K., Zheng, C., Li, W., Murtaza, I., Li, Y., et al. (2020) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2020.00096 · Cited by 82
Gut microbiota dysbiosis: The potential mechanisms by which alcohol disrupts gut and brain functions
Chen, G., Shi, F., Yin, W., Guo, Y., Liu, A., Shuai, J., & Sun, J. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.916765 · Cited by 99
“Activation of indoleamine 2,3-dioxygenase also affects LPS modification of 5-HT (O’Connor et al., 2009).”
BackgroundTargeting inflammation: a potential approach for the treatment of depression
Bhatt, S., Devadoss, T., Jha, N. K., Baidya, M., Gupta, G., Chellappan, D. K., Singh, S. K., & Dua, K. (2022) · Metabolic Brain Disease · doi:10.1007/s11011-022-01095-1 · Cited by 91
“When IDO is activated in conditions of chronic inflammation, its degree of activation is correlated to the intensity of depressive symptoms, as observed in cancer patients (O’Connor et al. 2009).”
BackgroundReininghaus, E. Z., McIntyre, R. S., Reininghaus, B., Geisler, S., Bengesser, S. A., Lackner, N., Hecht, K., Birner, A., Kattnig, F., Unterweger, R., et al. (2014) · Bipolar Disorders · doi:10.1111/bdi.12166 · Cited by 82
“Although much of the attention regarding IDO has been primarily focused on the depletion of tryptophan and further production of serotonin, data from laboratory animals have demonstrated that intraperitoneal administration of kynurenine can induce a depressive-like behavior (62).”
BackgroundSouza, L. C., Jessé, C. R., Antunes, M. S., Ruff, J. R., Janner, D. E., Gomes, N. S., Donato, F., Giacomeli, R., & Boeira, S. P. (2016) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2016.03.002 · Cited by 92
Ardalan, M., Chumak, T., Vexler, Z., & Mallard, C. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20092270 · Cited by 80
“Activation of the tryptophan-kynurenine pathway in microglia by immune challenges has been suggested to participate in the pathogenesis of depressive-like behaviors [205].”
BackgroundAguilar-Valles, A., Haji, N., De Gregorio, D., Matta-Camacho, E., Eslamizade, M. J., Popic, J., Sharma, V., Cao, R., Rummel, C., Tanti, A., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04883-5 · Cited by 82
Larkin, P. B., Sathyasaikumar, K. V., Notarangelo, F. M., Funakoshi, H., Nakamura, T., Schwarcz, R., & Muchowski, P. J. (2016) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2016.07.002 · Cited by 78
Jiang, J., Tang, B., Wang, L., Huo, Q., Tan, S., Misrani, A., Han, Y., Li, H., Hu, H.-D., Wang, J., et al. (2021) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2021.09.017 · Cited by 90
“Upregulation of the GABAAR α1 subunit usually reduces the half-width of inhibitory synaptic currents, a characteristic of mature inhibitory synapses (Okada et al., 2000; Vicini et al., 2001).”
BackgroundInfluentialGhanizadeh, A., & Hedayati, A. (2013) · Depression and Anxiety · doi:10.1002/da.22195 · Cited by 81
Bishnoi, I. R., Ossenkopp, K., & Kavaliers, M. (2020) · Developmental Psychobiology · doi:10.1002/dev.22037 · Cited by 86
Biesmans, S., Bouwknecht, J. A., Donck, L. V., Langlois, X., Acton, P. D., Haes, P. D., Davoodi, N., Meert, T. F., Hellings, N., & Nuydens, R. (2015) · BioMed Research International · doi:10.1155/2015/716920 · Cited by 91
Glia in the cytokine-mediated onset of depression: fine tuning the immune response
Jo, W. K., Zhang, Y., Emrich, H. M., & Dietrich, D. E. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00268 · Cited by 77
Hsing, C., Hung, S., Chen, Y.-C., Wei, T.-S., Sun, D., Wang, J.-J., & Yeh, C. (2015) · Mediators of Inflammation · doi:10.1155/2015/163140 · Cited by 86
“Inhibiting IDO activation prevents LPS-induced symptoms of depression, for example, anhedonia [16, 37].”
BackgroundLawson, M. A., McCusker, R. H., & Kelley, K. W. (2013) · Journal of Neuroinflammation · doi:10.1186/1742-2094-10-54 · Cited by 80
“Preclinical research using animals to model human depression has provided significant insight into which inflammatory mediators may be good therapeutic drug targets [9-12].”
BackgroundSelf-citationJi, W., Wang, S., Ma, Z., Li, R., Li, S., Xue, J., Li, W. S., Niu, X.-X., Lü, Y., Zhang, X., et al. (2013) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2013.10.026 · Cited by 85
“…studies, peripheral inflammation has been demonstrated to be involved in depressive-like behavior in mice treated with LPS, and peripheral administration of LPS induces depressive-like behavior in forced swimming test (FST) and tail suspension test (TST) (Kang et al., 2011; O'Connor et al., 2009).”
BackgroundInfluentialLiu, D., Ray, B., Neavin, D. R., Zhang, J., Athreya, A. P., Biernacka, J. M., Bobo, W. V., Hall-Flavin, D. K., Skime, M. K., Zhu, H., et al. (2018) · Translational Psychiatry · doi:10.1038/s41398-017-0056-8 · Cited by 78
Tang, X.-H., Zhang, G.-F., Xu, N., Duan, G.-F., Jia, M., Liu, R., Zhou, Z.-Q., & Yang, J.-J. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-01843-z · Cited by 79
The Kynurenine Pathway in Traumatic Brain Injury: Implications for Psychiatric Outcomes
Meier, T. B., & Savitz, J. B. (2021) · Biological Psychiatry · doi:10.1016/j.biopsych.2021.05.021 · Cited by 83
Hochstrasser, T., Ullrich, C., Sperner‐Unterweger, B., & Humpel, C. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.03.070 · Cited by 89
“In this respect, O’Connor et al. (2009) showed that IDO inhibition blocks depressive-like behavior in mice, implicating IDO as a critical mediator of inflammation-induced depressive-like behavior.”
Fiore, N. T., & Austin, P. J. (2016) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2016.04.012 · Cited by 88
“Increased expression of KYN and QUIN has been linked to depression in humans, as well as depressive-like behaviour in neuropathic and inflammatory chronic pain models (Kim et al., 2012; O'Connor et al., 2009; Walker et al., 2013; Zhou et al., 2015).”
Dey, A., & Hankey Giblin, P. A. (2018) · Pharmaceuticals · doi:10.3390/ph11030064 · Cited by 80
“IDO regulates the metabolism of kynurenine from tryptophan, and downstream metabolism of KYN leads to conversion of KYN into QA by an enzyme known as kynurenine-monooxygenase (KMO) [67,68].”
BackgroundModulating Neuroinflammation to Treat Neuropsychiatric Disorders
Radtke, F. A., Chapman, G., Hall, J., & Syed, Y. A. (2017) · BioMed Research International · doi:10.1155/2017/5071786 · Cited by 76
“tryptophan-degrading enzyme indoleamine 2,3-dioxygenase [50].”
Microglial glutaminase 1 deficiency mitigates neuroinflammation associated depression
Ji, C., Tang, Y., Zhang, Y., Li, C., Liang, H., Ding, L., Xia, X., Xiong, L., Qi, X., & Zheng, J. (2021) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2021.10.009 · Cited by 80
Huang, W., Chen, Y., Fedorov, A., Li, X., Jajamovich, G. H., Malyarenko, D. I., Aryal, M. P., LaViolette, P. S., Oborski, M. J., O’Sullivan, F., et al. (2019) · Tomography · doi:10.18383/j.tom.2018.00027 · Cited by 83
Resolvin E1/E2 ameliorate lipopolysaccharide-induced depression-like behaviors via ChemR23
Deyama, S., Shimoda, K., Suzuki, H., Ishikawa, Y., Ishimura, K., Fukuda, H., HitoraーImamura, N., Ide, S., Satoh, M., Kaneda, K., et al. (2017) · Psychopharmacology · doi:10.1007/s00213-017-4774-7 · Cited by 83
IDO and TDO as a potential therapeutic target in different types of depression
Qin, Y., Wang, N., Zhang, X., Han, X., Zhai, X., & Lu, Y. (2018) · Metabolic Brain Disease · doi:10.1007/s11011-018-0290-7 · Cited by 81
Sleep disturbance and kynurenine metabolism in depression
Cho, H. J., Savitz, J. B., Dantzer, R., Teague, T. K., Drevets, W. C., & Irwin, M. R. (2017) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2017.05.016 · Cited by 81
Self-citationNeuroinflammation, Microbiota-Gut-Brain Axis, and Depression: The Vicious Circle
Reyes-Martínez, S., Segura-Real, L., Gómez-García, A. P., Tesoro-Cruz, E., Constantino-Jonapa, L. A., Amedei, A., & Aguirre‐García, M. M. (2023) · Journal of Integrative Neuroscience · doi:10.31083/j.jin2203065 · Cited by 92
Swardfager, W., Hennebelle, M., Yu, D., Hammock, B. D., LEVITT, A. J., Hashimoto, K., & Taha, A. Y. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.01.010 · Cited by 82
Skelly, D. T., Hennessy, E., Dansereau, M.-A., & Cunningham, C. (2013) · PLoS ONE · doi:10.1371/annotation/90c76048-2edd-4315-8404-4d9d8cbd411e · Cited by 77
Visentin, A. P. V., Colombo, R., Scotton, E., Fracasso, D. S., Rosa, A. R., Branco, C. S., & Salvador, M. M. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/2972968 · Cited by 88
“Some of these cytokines activate the enzymes indoleamine 2,3-dioxygenase (IDO) and tryptophan 2,3-dioxygenase (TDO) from the kynurenine pathway, diverting tryptophan from its main route of serotonin production [18–20].”
BackgroundInfluentialOrtega, M. A., Fraile‐Μartinez, O., Montero, C. G., Álvarez-Mon, M. Á., Lahera, G., Monserrat, J., Llavero-Valero, M., Gutiérrez-Rojas, L., Molina, R., Rodríguez–Jiménez, R., et al. (2022) · Nutrients · doi:10.3390/nu14153099 · Cited by 89
Of mice and men: modelling post‐stroke depression experimentally
Kronenberg, G., Gertz, K. R., Heinz, A., & Endres, M. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12775 · Cited by 81
“Similarly, peripheral administration of LPS was shown to activate IDO and thereby culminate in a distinct depressive-like behavioural syndrome, probably mediated through tryptophan catabolites (O’Connor et al., 2009b).”
BackgroundMinocycline protects against lipopolysaccharide-induced cognitive impairment in mice
Hou, Y., Xie, G., Liu, X., Li, G., Jia, C., Xu, J., & Wang, B. (2015) · Psychopharmacology · doi:10.1007/s00213-015-4169-6 · Cited by 83
Hestad, K. A., Engedal, K., Whist, J. E., & Farup, P. G. (2017) · Frontiers in Psychology · doi:10.3389/fpsyg.2017.01561 · Cited by 72
“It has been suggested that the metabolic enzyme indoleamine 2,3-dioxygenase (IDO) is a biological mediator of inflammation related to depressive disorders, as seen in animal models and after drug therapy in humans with interferon-α (O’Connor et al., 2009a,b; Raison et al., 2010).”
BackgroundSakurai, M., Yamamoto, Y., Kanayama, N., Hasegawa, M., Mouri, A., Takemura, M., Matsunami, H., Miyauchi, T., Tokura, T., Kimura, H., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-58806-w · Cited by 81
Inhibition of activated astrocyte ameliorates lipopolysaccharide- induced depressive-like behaviors
Wang, Y., Ni, J., Zhai, L., Gao, C., Xie, L., Zhao, L., & Yin, X. (2019) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.08.015 · Cited by 75
Sekio, M., & Seki, K. (2015) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyu005 · Cited by 75
“Results: At 24 h after the second administration of LPS, an increased immobility time in the tail suspension test and the forced swimming test were observed, as well as reduced sucrose preference.”
BackgroundAlzarea, S., & Rahman, S. (2019) · Behavioural Brain Research · doi:10.1016/j.bbr.2019.03.019 · Cited by 75
“However, future studies may be required to confirm this notion Moreover, it is noteworthy to mention that the production of proinflammatory cytokines in the brain by LPS also impacts serotonin level as reflected in increased serotonin turnover [51,95].”
InfluentialThe inflammatory underpinning of depression: An historical perspective
Yirmiya, R. (2024) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2024.08.048 · Cited by 87
Inflammation and Immune Regulation as Potential Drug Targets in Antidepressant Treatment
Schmidt, F. M., Kirkby, K. C., & Lichtblau, N. (2016) · Current Neuropharmacology · doi:10.2174/1570159x14666160115130414 · Cited by 82
Brain interference: Revisiting the role of IFNγ in the central nervous system
Monteiro, S., Roque, S., Marques, F., Correia‐Neves, M., & Cerqueira, J. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2017.05.003 · Cited by 80
Jiang, X., Liu, J., Lin, Q., Mao, K., Tian, F., Jing, C., Wang, C., Ding, L., & Pang, C. (2017) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2017.09.010 · Cited by 78
“The dose of LPS used was selected based on previous studies (O’Connor et al., 2009; Sulakhiya et al., 2016).”
MethodFredericks, C. A., Drabant, E. M., Edge, M. D., Tillie, J. M., Hallmayer, J., Ramel, W., Kuo, J. R., Mackey, S., Gross, J. J., & Dhabhar, F. S. (2010) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2009.10.014 · Cited by 74
“In animal models, depression-like behavior induced by LPS, a common component of pathogenic bacterial cell walls, is mediated by IDO (O’Connor et al., 2009).”
BackgroundKhandaker, G. M., Oltean, B. P., Kaser, M., Dibben, C. R. M., Ramana, R., Jadon, D. R., Dantzer, R., Coles, A. J., Lewis, G., & Jones, P. B. (2018) · BMJ Open · doi:10.1136/bmjopen-2018-025333 · Cited by 74
Self-citationKynurenic acid is reduced in females and oral contraceptive users: Implications for depression
Meier, T. B., Drevets, W. C., Teague, T. K., Wurfel, B. E., Mueller, S. C., Bodurka, J., Dantzer, R., & Savitz, J. B. (2017) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2017.08.024 · Cited by 103
Self-citationNicolas, S., Debayle, D., Béchade, C., Maroteaux, L., Gay, A.-S., Bayer, P., Heurteaux, C., Guyon, A., & Chabry, J. (2018) · Translational Psychiatry · doi:10.1038/s41398-018-0210-y · Cited by 73
Gu, M., Li, Y., Tang, H., Zhang, C., Li, W., Zhang, Y., Li, Y., Zhao, Y., & Song, C. (2018) · Nutrients · doi:10.3390/nu10101351 · Cited by 73
Rummel, C. D. (2015) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2015.09.003 · Cited by 76
Poon, D. C.-H., Ho, J. Y. S., Chiu, K., Wong, H.-L., & Chang, R. C. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.07.015 · Cited by 84
Cancer induces inflammation and depressive-like behavior in the mouse: Modulation by social housing
Lamkin, D. M., Lutgendorf, S. K., Lubaroff, D. M., Sood, A. K., Beltz, T. G., & Johnson, A. K. (2010) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2010.12.010 · Cited by 81
Savitz, J., Preskorn, S., Teague, T. K., Drevets, D., Yates, W., & Drevets, W. (2012) · BMJ Open · doi:10.1136/bmjopen-2011-000643 · Cited by 73
“61 Levine et al 62 presented the case of a 66-year-old woman with severe BD, who observed that the tetracycline she took for an infection alleviated her depression.”
BackgroundGuo, J., Lin, P., Zhao, X., Zhang, J., Wei, X., Wang, Q., & Wang, C. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.01.008 · Cited by 75
“Given that the close link between peripheral inflammation and depression (Dantzer, 2006, 2012; O’Connor et al., 2009; Gałecki et al., 2012; Leonard and Maes, 2012; Maes, 2008, 2010; Maes et al., 2012), it is reasonable to predict a beneficial effect of anti-inflammatory therapy on depression-like behavior.”
Finnell, J. E., & Wood, S. K. (2016) · Neurobiology of Stress · doi:10.1016/j.ynstr.2016.04.001 · Cited by 67
“…KYN pathway in depression as direct injection of KYN is capable of producing a depressive-like effect (O'Connor et al., 2009b) and pharmacological inhibition of IDO, or the use of IDO deficient mice, reverses the depressive-like effects of endotoxin administration (O'Connor et al., 2009a).”
The role and mechanism of tryptophan – kynurenine metabolic pathway in depression
Gong, X., Chang, R., Zou, J., Tan, S., & Huang, Z. (2022) · Reviews in the Neurosciences · doi:10.1515/revneuro-2022-0047 · Cited by 78
Fritz, M., Klawonn, A. M., Nilsson, A., Singh, A. K., Zajdel, J., Björk Wilhelms, D., Lazarus, M., Löfberg, A., Jaarola, M., Örtegren Kugelberg, U., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci83844 · Cited by 72
“Whereas we examined how mild acute inflammation induces discomfort and negative affect, others have studied the mechanisms behind inflammation-induced despair-like behavior in rodents using the forced-swim tests or tail-suspension tests (6, 34, 50).”
BackgroundMethodKocki, T., Wnuk, S., Kloc, R., Kocki, J., Owe‐Larsson, B., & Urbańska, E. M. (2011) · Journal of Neural Transmission · doi:10.1007/s00702-011-0668-8 · Cited by 81
“Pro-inflammatory cytokines induce depression-like behavioral changes in experimental animals as well as alterations of sleeping patterns, cognition and mood changes in humans treated, e.g. with interferon-a (IFN-a) (Bonaccorso et al. 2002; Miura et al. 2008; O’Connor et al. 2009).”
BackgroundMicroglia depletion fails to abrogate inflammation-induced sickness in mice and rats
Vichaya, E. G., Malik, S., Sominsky, L., Ford, B. G., Spencer, S. J., & Dantzer, R. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-01832-2 · Cited by 68
“The key role of brain microglia in the development of inflammation-induced behavioral alterations has been demonstrated by various approaches mainly aiming at counteracting the production and action of inflammatory cytokines(7) or at normalizing microglial proinflammatory activity and phagocytosis using minocycline(8,…”
BackgroundSelf-citationDüsedau, H. P., Steffen, J., Figueiredo, C. A., Boehme, J. D., Schultz, K., Erck, C., Körte, M., Faber‐Zuschratter, H., Smalla, K., Dieterich, D. C., et al. (2021) · mBio · doi:10.1128/mbio.01776-21 · Cited by 84
Laugeray, A., Launay, J., Callebert, J., Surget, A., Belzung, C., & Barone, P. R. (2010) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2010.12.008 · Cited by 72
“Similarly, a large preclinical evidence suggests that activation of the peripheral KP is related to the expression of a depressive-like syndrome (O'Connor et al., 2008).”
BackgroundInfluentialWirthgen, E., & Hoeflich, A. (2015) · Journal of Amino Acids · doi:10.1155/2015/973548 · Cited by 73
Chronic psychological stress and lower urinary tract symptoms
Chess‐Williams, R., McDermott, C., Sellers, D., West, E. G., & Mills, K. (2021) · LUTS Lower Urinary Tract Symptoms · doi:10.1111/luts.12395 · Cited by 76
Prowse, N. A., & Hayley, S. P. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.09.018 · Cited by 78
High-mobility group box-1 was released actively and involved in LPS induced depressive-like behavior
Wu, T., Liu, L., Zhang, W., Zhang, Y., Liu, Y., Shen, X.-L., Gong, H., Yang, Y., Bi, X., Jiang, C., et al. (2015) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2015.02.016 · Cited by 72
“1C), which is consistent with other reports (O'Connor et al., 2009).”
BackgroundResultLeistner, C., & Menke, A. (2018) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2018.01.023 · Cited by 69
Major Depressive Disorder and Gut Microbiota: Role of Physical Exercise
de Souza, P. B., Borba, L. A., de Jesus, L. C., Valverde, A. P., Gil‐Mohapel, J., & Rodrigues, A. L. S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242316870 · Cited by 73
“Another key inflammatory mechanism implicated in LPS-induced depressive-like behavior is the tryptophan (Trp)–kynurenine metabolism [14].”
BackgroundAntidepressant-like effects of β-caryophyllene on restraint plus stress-induced depression
Hwang, E., Kim, H.-B., Lee, S., Kim, M. J., Kim, K.-J., Han, G., Han, S.-Y., Lee, E.-A., Yoon, J.-H., Kim, D., et al. (2019) · Behavioural Brain Research · doi:10.1016/j.bbr.2019.112439 · Cited by 76
The possible role of the kynurenine pathway in anhedonia in adolescents
Gabbay, V., Ely, B. A., Babb, J., & Liebes, L. (2012) · Journal of Neural Transmission · doi:10.1007/s00702-011-0685-7 · Cited by 67
“of depressive-like behaviors in mice following LPS (O’Connor et al. 2008).”
BackgroundInfluentialFarzi, A., Reichmann, F., Meinitzer, A., Mayerhofer, R., Jain, P., Hassan, A. M., Fröhlich, E. E., Wagner, K., Painsipp, E., Rinner, B., et al. (2015) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2014.08.011 · Cited by 68
“The increase in plasma tryptophan seen here contrasts with a decrease of tryptophan seen in other studies (O’connor et al., 2009) but may be related to the TST employed 30 min before blood sampling, given that stress can increase peripheral tryptophan levels in rodents, but the underlying mechanisms are not understood…”
InfluentialA Proposed Role for Pro-Inflammatory Cytokines in Damaging Behavior in Pigs
Nordgreen, J., Edwards, S. A., Boyle, L. A., Bolhuis, J. E., Veit, C., Sayyari, A., Marin, D. E., Dimitrov, I., Janczak, A. M., & Valros, A. (2020) · Frontiers in Veterinary Science · doi:10.3389/fvets.2020.00646 · Cited by 71
“The depression-like changes in behavior were blocked by treatments inhibiting IDO activity directly or indirectly, but without any influence on the LPS-induced increase in serotonin turnover (33).”
BackgroundFlorensa-Zanuy, E., Garro-Martínez, E., Adell, A., Castro, E., Díaz, Á., Pazos, Á., Mac-Dowell, K. S., Martín-Hernández, D., & Pilar-Cuéllar, F. (2021) · Biochemical Pharmacology · doi:10.1016/j.bcp.2021.114433 · Cited by 66
Inflammation, stress and depression: An exploration of ketamine’s therapeutic profile
Johnston, J. N., Greenwald, M. S., Henter, I. D., Kraus, C., Mkrtchian, A., Clark, N. G., Park, L. T., Gold, P. W., Zarate, C. A., & Kadriu, B. (2023) · Drug Discovery Today · doi:10.1016/j.drudis.2023.103518 · Cited by 80
O'Connor, T. G., Moynihan, J. A., & Caserta, M. T. (2014) · Journal of Child Psychology and Psychiatry · doi:10.1111/jcpp.12187 · Cited by 65
Deletion of TDO2, IDO-1 and IDO-2 differentially affects mouse behavior and cognitive function
Too, L. K., Li, K. M., Suarna, C., Maghzal, G. J., Stocker, R., McGregor, I. S., & Hunt, N. H. (2016) · Behavioural Brain Research · doi:10.1016/j.bbr.2016.06.018 · Cited by 72
“Administration of a competitive antagonist of IDO, 1-methyl-D,L-tryptophan (1-MT), can alleviate the behavioral abnormalities seen with bacille Calmette-Guérin- or LPS-induced murine systemic inflammation [12, 13].”
Ma, M., Ren, Q., Yang, C., Zhang, J.-C., Yao, W., Dong, C., Ohgi, Y., Futamura, T., & Hashimoto, K. (2017) · Psychopharmacology · doi:10.1007/s00213-016-4483-7 · Cited by 69
Cai, T., Zheng, S.-P., Shi, X., Yuan, L., Hu, H., Bai, Z., Xiao, S.-L., & Wang, F. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.900652 · Cited by 71
“Following an injection into mice with a low dose of LPS, the immune system rapidly activates, which was found to lead to depression-like behavior (O’Connor et al., 2009).”
MethodThe influence of inflammatory cytokines in physiopathology of suicidal behavior
Miná, V. A. L., Lacerda-Pinheiro, S. D. F., Maia, L. C., Pinheiro, R. F. F., Meireles, C. B., de Souza, S. I. R., Reis, A. O. A., Bianco, B. A. V., & Rolim, M. L. N. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.09.057 · Cited by 71
“In concordance, IFN-α is described to decrease serotonin (5-HT) and dopamine biosynthesis rates, as well as to activate monoamine transporters, thus depleting the synaptic concentration of this neurotransmitters (Morikawa et al., 1998; O'Connor et al., 2009; Zhao et al., 2011; Huang and Chen, 2005).”
BackgroundZhang, J.-C., Yao, W., Ren, Q., Yang, C., Dong, C., Ma, M., Wu, J., & Hashimoto, K. (2016) · Scientific Reports · doi:10.1038/srep36705 · Cited by 86
“Peripheral administration of the bacterial endotoxin lipopolysaccharide (LPS) can induce depression-like behavior and alteration in serum pro-inflammatory cytokines in mice 1,6,46 .”
Indoleamine 2,3-dioxygenase as a new target for malignant glioma therapy: Laboratory investigation
Miyazaki, T., Moritake, K., Yamada, K., Hara, N., Osago, H., Shibata, T., Akiyama, Y., & Tsuchiya, M. (2009) · Journal of neurosurgery · doi:10.3171/2008.10.jns081141 · Cited by 72
Zheng, X., Liang, Y. L., An, K., Ma, S.-J., Xing, L., Zhou, Y.-Y., Dai, C., Xie, H., Xie, L., Wang, G.-J., et al. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.10.023 · Cited by 69
Park, S.-E., Lawson, M., Dantzer, R., Kelley, K. W., & McCusker, R. H. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-179 · Cited by 65
Self-citationRen, Z., Yan, P., Zhu, L.-S., Yang, H., Zhao, Y., Kirby, B. P., Waddington, J. L., & Zhen, X. (2017) · Psychopharmacology · doi:10.1007/s00213-017-4761-z · Cited by 66
“sponse to antidepressant treatment (Hughes et al. 2016; O’Connor et al. 2009; Rapaport et al. 2015).”
Brain-immune crosstalk in the treatment of major depressive disorder
Branchi, I., Poggini, S., Capuron, L., Benedetti, F., Poletti, S., Tamouza, R., Drexhage, H. A., Penninx, B. W. J. H., & Pariante, C. M. (2021) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2020.11.016 · Cited by 64
Targeting the Immunoregulatory Indoleamine 2,3 Dioxygenase Pathway in Immunotherapy
rd, B. A. J., Baban, B., & Mellor, A. L. (2009) · Immunotherapy · doi:10.2217/imt.09.21 · Cited by 68
Li, T., Zheng, L.-N., & Han, X.-H. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109680 · Cited by 64
Metadata
- Authors
- O'Connor, J. C., Lawson, M. A., André, C., Moreau, M., Lestage, J., Castanon, N., Kelley, K. W., & Dantzer, R.
- Affiliations
- University of Illinois Urbana-Champaign (US)
- Centre National de la Recherche Scientifique (FR)
- Corresponding author
- Dantzer, R
- Venue
- Molecular Psychiatry
- Published
- 2008-01-15
- Volume
- 14
- Issue
- 5
- Pages
- 511-522
- ISSN
- 1359-4184 (ISSN-L)
- 1476-5578
- PMC
- PMC2683474
- OpenAlex
- W2050508296
- Cited by
- 1,278
- References
- 56
- Citations by year
- 2026: 45 · 2025: 68 · 2024: 82 · 2023: 86 · 2022: 94 · 2021: 106 · 2020: 88 · 2019: 86 · 2018: 95 · 2017: 87 · 2016: 88 · 2015: 76 · 2014: 61 · 2013: 71 · 2012: 38
- FWCI
- 11.47
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Molecular Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- HAL (submittedVersion)
- Funders
- National Institutes of Health
- National Institute on Aging (R01AG029573)
- National Institute of Mental Health (R01MH079829, R01MH071349, R01 MH-71349)
- National Institute of Diabetes and Digestive and Kidney Diseases (T32DK059802, T32 DK59802-01)
- Topics
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Keywords
- indoleamine 2,3-dioxygenase, lipopolysaccharide, depression-like behavior, kynurenine pathway, tryptophan catabolism, minocycline, 1-methyltryptophan, L-kynurenine, kynurenine/tryptophan ratio, serotonin turnover, inflammatory cytokines, comorbid depression
- MeSH terms
- Animals, Behavior, Animal, Chromatography, High Pressure Liquid, Cytokinins, Depression, Disease Models, Animal, Dose-Response Relationship, Drug, Enzyme Activation, Enzyme Inhibitors, Gene Expression Regulation, Kynurenine, Lipopolysaccharides, Male, Mice, Inbred ICR, Minocycline, Motor Activity, Swimming, Time Factors, Tryptophan, Hindlimb Suspension, Indoleamine-Pyrrole 2,3,-Dioxygenase, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.